DETERMINATION OF QUERCETIN IN HUMAN PLASMA USING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引:43
作者
LIU, B [1 ]
ANDERSON, D [1 ]
FERRY, DR [1 ]
SEYMOUR, LW [1 ]
DETAKATS, PG [1 ]
KERR, DJ [1 ]
机构
[1] UNIV BIRMINGHAM,SCH MED,CRC,INST CANC STUDIES,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1995年 / 666卷 / 01期
关键词
D O I
10.1016/0378-4347(94)00549-K
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A method is reported for the measurement of quercetin in human plasma using reversed-phase high-performance liquid chromatography (HPLC). Quercetin and kaempferol (as internal standard) were spiked into plasma samples and extracted using C-18 Sep-Pak Light cartridges (efficiency > 85%). Flavonoids were eluted with aqueous acetone (50% v/v, pH 3.5), dried down and redissolved in aqueous acetone (45% v/v, pH 3.5). The increased osmolarity promoted a phase separation and the water-saturated acetone layer, containing the flavonoids, was analysed by HPLC with aqueous acetone mobile phase (45% viv acetone in 250 mM sodium dihydrogen sulphate. The mixture was adjusted to pH 3.5 with phosphoric acid and used at a flow-rate of 1.0 ml/min) and mu Bondapak C-18 column (150 x 3.9 mm I.D., 10 mu m particle size). The detection limit (A(375nm)) for quercetin in plasma was 0.1 mu g/ml (300 nM). The method also detects metabolites of quercetin, although these are not yet identified.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 18 条
[1]  
ANTON R, 1988, PLANT FLAVONOIDS BIO, V2, P423
[2]  
BENNETT JP, 1981, ARZNEIMITTEL-FORSCH, V31-1, P433
[3]  
BOKKENHEUSER VD, 1988, PLANT FLAVONOIDS BIO, V2, P143
[4]   FLAVONOID MODULATION OF HUMAN NEUTROPHIL FUNCTION [J].
BUSSE, WW ;
KOPP, DE ;
MIDDLETON, E .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (06) :801-809
[5]  
FERRY DR, 1995, UNPUB
[6]   ON THE MECHANISM OF ANTITHROMBOTIC ACTION OF FLAVONOIDS [J].
GRYGLEWSKI, RJ ;
KORBUT, R ;
ROBAK, J ;
SWIES, J .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (03) :317-322
[7]  
GUGLER R, 1973, CLIN CHEM, V19, P36
[8]   DISPOSITION OF QUERCETIN IN MAN AFTER SINGLE ORAL AND INTRAVENOUS DOSES [J].
GUGLER, R ;
LESCHIK, M ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :229-234
[9]   ENHANCEMENT OF THE ANTIPROLIFERATIVE ACTIVITY OF CIS-DIAMMINEDICHLOROPLATINUM(II) BY QUERCETIN [J].
HOFMANN, J ;
FIEBIG, HH ;
WINTERHALTER, BR ;
BERGER, DP ;
GRUNICKE, H .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :536-539
[10]   ENHANCEMENT OF THE ANTIPROLIFERATIVE EFFECT OF CIS-DIAMMINEDICHLOROPLATINUM(II) AND NITROGEN-MUSTARD BY INHIBITORS OF PROTEIN KINASE-C [J].
HOFMANN, J ;
DOPPLER, W ;
JAKOB, A ;
MALY, K ;
POSCH, L ;
UBERALL, F ;
GRUNICKE, HH .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :382-388